European Companies Search Engine

EU funding (€149,156): Therapeutic potential of optimized derivatives of an endogenous CXCR4 antagonist for the treatment of cancers and inflammatory diseases Hor1 Sept 2018 EU Research and Innovation programme "Horizon"

Overview

Text

The filing refers to a past date, and does not necessarily reflect the current state.

Creative Commons License The visualizations for "FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG e. V. - EU funding (€149,156): Therapeutic potential of optimized derivatives of an endogenous CXCR4 antagonist for the treatment of cancers and inflammatory diseases" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.